11:36 AM EST, 01/07/2025 (MT Newswires) -- Achieve Life Sciences ( ACHV ) completed the US Food and Drug Administration long-term exposure requirement for cytisinicline, a treatment designed to help people quit smoking, with no safety concerns identified.

More than 300 participants completed six months of cumulative cytisinicline treatment in the ORCA-OL clinical trial, the company said Tuesday in a statement.

The company remains on track for the planned New Drug Application submission in Q2.

The company's shares rose 6.2% in recent Tuesday trading.

Price: 3.77, Change: +0.22, Percent Change: +6.20